Okay, thank you. Let me introduce our project, MONSTAR-SCREEN-2. Yes, Scrum Japan Monster Screen is the translation research target for the patient with advanced tumors. And in this study, we analyzed some genomic analysis, including the tissue whole exome sequencing and tissue whole transcriptome sequencing and the blood-based whole exome sequencing and whole transcriptome sequencing was performed...
Okay, thank you. Let me introduce our project, MONSTAR-SCREEN-2. Yes, Scrum Japan Monster Screen is the translation research target for the patient with advanced tumors. And in this study, we analyzed some genomic analysis, including the tissue whole exome sequencing and tissue whole transcriptome sequencing and the blood-based whole exome sequencing and whole transcriptome sequencing was performed. Regarding the tissue and the blood whole exome NGS testing are performed by the Claris Life Sciences in US. And we analyzed the tissue and the blood NGS testing before initiation of the systemic therapy and after progression of systemic therapy. And we would like to detect the molecular targets of the patients and evaluate the molecular resistance mechanism to analyze the tissue samples after the progression after the disease progression.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
